CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 8-K Event Executive or director change
- 4 Planned sale Chief Commercial Officer sold 6,272 shares at $0.55 ($3,450)
- 4 Planned sale See Remarks sold 6,863 shares at $0.55 ($3,775)
- 4 Planned sale Chief Scientific Officer sold 7,175 shares at $0.55 ($3,946)
- 4 Planned sale Chief Financial Officer sold 7,175 shares at $0.55 ($3,946)
- 4 Planned sale See Remarks sold 5,556 shares at $0.55 ($3,056)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Delisting notice
- 8-K Event Exit or restructuring costs · Executive or director change
- 4 Planned sale Chief Scientific Officer sold 355 shares at $0.69 ($245)
- 4 Planned sale CEO and President sold 1,982 shares at an average $0.69 ($1,367)
- 4 Planned sale Chief Financial Officer sold 356 shares at $0.69 ($246)
- 4 Planned sale See Remarks sold 345 shares at $0.69 ($238)
- 4 Planned sale See Remarks sold 138 shares at $0.69 ($95)
- 4 Planned sale Chief Commercial Officer sold 215 shares at $0.69 ($149)
- 4/A Derivatives Options or other derivatives
Page 10 of 34 · 672 filings